ACT TV Library - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
ACT TV Library

Source: Applied Clinical Trials


Safety In Pediatric Trials
In this segment, Kathryn Elaine Bohannon, Principal Strategist, Pediatrics, INC Research discusses how IRBs and Data Safety Monitoring Boards examine clinical trials in children.
Watch here>>

 


Changing Role Of The Study Monitor
Penelope K. Manasco, CEO, MANA Consulting, discusses how RBM is changing the role of the study monitor and discusses the competencies site managers will need moving forward.
Watch here>>

 


eConsent’s Impact on Patients
Lindsay McNair, MD, MPH, MS, Chief Clinical Research Officer, WIRB-Copernicus IRB, describes how eConsent changes the consent process.
Watch here>>

 


Social Media Listening
In this video, Melissa Mottolo, Patient Strategist Associate, Genentech, discusses how the sponsor uses social media as a way to improve the patient's experience in clinical trials.
Watch here>>

 


The Importance of Clinical Research Sites
Christine K. Pierre, RN, President, Society for Clinical Research Sites, discusses how SCRS is growing and the initiatives it is offering for more meaningful site engagement for CROs and sponsors.
Watch here>>

 


eConsent’s Impact on Patients
Lindsay McNair, MD, MPH, MS, Chief Clinical Research Officer, WIRB-Copernicus IRB, describes how eConsent changes the consent process.
Watch here>>

 


Social Media Listening
In this video, Melissa Mottolo, Patient Strategist Associate, Genentech, discusses how the sponsor uses social media as a way to improve the patient's experience in clinical trials.
Watch here>>

 


Quality Metrics In Clinical Trials
Linda B. Sullivan, MBA, Chief Operating Officer, Metrics Champion Consortium, says FDA guidance on Quality by Design, as well as warning letters, have contributed to the demand for quality in clinical trials.
Watch here>>

 


A Report On Paul Wicks, Head of Innovation, PatientsLikeMe
In this report, Editor Lisa Henderson discusses a recent interview with Paul Wicks and the new services for pharma that PatientsLikeMe introduced at DIA. Learn more about the learning healthcare system, which features patients at the center of the new paradigm.
Watch here>>



 


Orphan Drug Development
In this segment, CEO of Prolong Pharmaceuticals, Abraham Abuchowski, discusses the challenges and opportunities in orphan drug development. Specifically, the outcomes, recruitment, and global reach necessary in drug development for smaller populations.
Watch here>>



 


Rare Disease Pipeline
In this segment, CEO of Prolong Pharmaceuticals, Abraham Abuchowski, discusses its products in clinical development in the hematology/oncology space.
Watch here>>



 


RBM Economics 101
High risk activities and high risk data are discussed by David Knepper, Head of Continuous Improvement, Forest Labs (now Actavis). Central to the focus is Risk-Based Monitoring, as well as Quality by Design built into clinical trials. 
Watch here>>



 


Patient Centricity Today
Anne Zielinski, Global Lead for the Patient Cloud at Medidata Solutions, discusses the key trends in patient-centric clinical trials, including social media and the opportunities of mHealth.
Watch here>>



 


Keys to RBM Success
Moe Alsumidiae, President and Chief Scientific Officer, Annex Clinical, breaks down the Keys to RBM success, including the growth in IT infrastructure in this sector, the need to re-define risk in the qualitative and quantitative perspectives, and the need to close the gap in the skill sets.
Watch here>>



 


Pharmacist: The Trust Factor in Patient Engagement
In this video, Moe Alsumidiae, President and Chief Scientific Officer, Annex Clinical, discusses the opportunities to leverage the trust patients have in their pharmacists, and the pros and cons of implementing clinical trials at the pharmacy level.
Watch here>>



 


Industry Trends 2014
Moe Alsumidiae, President and Chief Scientific Officer, Annex Clinical, reviews what he sees as new trends, including eConsents, Risk-Based Monitoring advanced analytical systems, and customized database integration in IT, in addition to the progress TransCelerate has made with their initiatives.
Watch here>>



 


Patient Reported Outcomes Today
Joseph Jackson, Associate Professior, Thomas Jefferson University, Program Director, Applied Health Economics and Outcomes Research Master's Degree, discusses his experiences with ePRO, the increase of the use of ePRO in clinical trials, and the use of social media and internet communications for amplifying patient voices.
Watch here>>



 


PCORI Initiatives
In this video, Joe Selby, MD, MPH, the Executive Director, Patient Centered Outcomes Research Institute (PCORI) discusses the institute's involvement in the clinical trials industry, including interest in PRO and building a better infrastructure for trials, and the goals for PCORI's National Clinical Research Network (NCRN) .
Watch here>>

 

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here